VIRAX BIOLABS GROUP LTD SHS NEW - Stock (VRAX)

CUSIP: G9495L109

Q3 2023 13F Holders as of 30 Sep 2023

Type / Class
Equity / Stock
Total 13F shares
33,509
Share change
-23,829
Total reported value
$10,891
Price per share
$0.32
Number of holders
4
Value change
-$11,742
Number of buys
3
Number of sells
3

Quarterly Holders Quick Answers

What is CUSIP G9495L109?
CUSIP G9495L109 identifies VRAX - VIRAX BIOLABS GROUP LTD SHS NEW - Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of VIRAX BIOLABS GROUP LTD SHS NEW - Stock (VRAX) as of Q3 2023

As of 30 Sep 2023, VIRAX BIOLABS GROUP LTD SHS NEW - Stock (VRAX) was held by 4 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 33,509 shares. The largest 4 holders included CITADEL ADVISORS LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, WELLS FARGO & COMPANY/MN, and UBS Group AG. This page lists 4 institutional shareholders reporting positions in this security for the Q3 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.